What's new AAPOS 2008 - The Private Eye Clinic

More documents

Recommendations

Info

AMBLYOPIA Relative Scotomata in the "Normal" Eye of Functionally Amblyopic Patients. A Scanning Laser Ophthalmoscope (SLO) Micreperimetric Study. Johnson DA. Binocul Vis Strabismus Q. 2007;22(1):17-48. In this retrospective case series, selected for SLO testing case series, clinical data of forty-six patients with amblyopia were reviewed after completion of treatment for anisometropic or strabismic amblyopia. Ten ophthalmologically age-matched, normal patients served as controls. All patients were tested with the SLO, evaluating for the presence of macular scotomata. SLO findings were assessed within each group and between groups. A macular scotoma was found in the amblyopic eye of 25 of 26 anisometropic amblyopic patients and all 20 strabismic amblyopia patients. Twenty of 26 patients with anisometropic amblyopia had a relative scotoma in the non-amblyopic "normal" eye. All 20 patients with strabismic amblyopia also had a non-amblyopic "normal" contralateral eye scotoma. None of the normal control patients had a scotoma in either eye. Several ocular and binocular clinical features were correlated to scotoma findings within and between groups. CONCLUSION: The SLO proved useful for the assessment of some features of amblyopia. A scotoma was identified not only in the amblyopic eye of all but one amblyopic patient, as expected, but also in almost all of the fellow non- amblyopic, presumed "normal" contralateral eyes, and in spite of treatment normalization of visual acuity and stereoacuity in several cases. Thus, the ocular and binocular pathological effects of unilaterally functional amblyopia are not limited to the amblyopic eye but may also be seen, to a sub-clinical degree. Long term vision outcomes of conventional treatment of strabismic and anisometropic functional amblyopia. Garoufalis P, Georgievski Z, Koklanis K. Binocul Vis Strabismus Q. 2007;22(1):49-56 The purpose of this study was to investigate the long-term vision outcomes of amblyopia treatment in "successfully" compared with "unsuccessfully" treated patients. Forty-two participants (n=42, mean age 14.8 years, range 10-25 years) were enrolled in the study. Individuals with strabismic or mixed (strabismic and anisometropic) amblyopia were examined at a mean of 6.6 years (range 1-18 years) after cessation of amblyopia treatment. Participants were classified as being "successfully" treated (Group 1) if visual acuity of 6/7.5 or better was achieved at cessation of treatment, or "unsuccessfully" treated (Group 2) if visual acuity of 6/9 or less was achieved at cessation of treatment. Visual acuity was analyzed by calculating an interocular score or difference in visual acuity between the amblyopic and non amblyopic normal (control) eye. A deterioration of visual acuity occurred in 62% of the participants in both Groups 1 and 2. The mean deterioration of visual acuity over time for either group was less than one LogMAR chart line and was not "statistically significant" by convention. The 48
outcomes achieved at cessation of treatment did not "statistically significantly" affect the mean deterioration that occurred over time Visual acuity was relatively stable over a mean followup period of 6.6 years. The treatment outcome and the success of amblyopia treatment were found to be irrelevant to long term stability of visual acuity. These findings suggest that amblyopia treatment mostly results in a lasting improvement in visual acuity, and that both unsuccessfully and successfully treated individuals maintain their visual acuity improvement achieved during treatment. Treatment of strabismic amblyopia with refractive correction. Cotter SA, Edwards AR, Arnold RW, Astle WF, Barnhardt CN, Beck RW, Birch EE, Donahue SP, Everett DF, Felius J, Holmes JM, Kraker RT, Melia BM, Repka MX, Wallace DK, Weise KK; Pediatric Eye Disease Investigator Group. Am J Ophthalmol. 2007 Jun;143(6):1060-3. PURPOSE: To report data on the response of previously untreated strabismic amblyopia to spectacle correction. METHODS: Twelve patients with previously untreated strabismic amblyopia were prescribed spectacles and examined at five-week intervals until visual acuity was not improved from the prior visit. RESULTS: Amblyopic eye acuity improved by 2 lines or more from spectacle-corrected baseline acuity in nine of the 12 patients (75%), resolving in three (interocular difference
Page 1 and 2: What’s New and Important in Pedia
Page 3 and 4: ROP Retinopathy of Prematurity: the
Page 5 and 6: same diagnosis in 4 of 34 images (1
Page 7 and 8: PREMATURITY Perinatal care in the t
Page 9 and 10: STRABISMUS Causes and outcomes for
Page 11 and 12: METHODS: The medical records of all
Page 13 and 14: initial positive response to medica
Page 15 and 16: deviation as an intermittent exodev
Page 17 and 18: STRABISMUS SURGERY Unilateral reces
Page 19 and 20: The effect of topical tetracaine ey
Page 21 and 22: +/-0.08 and 0.34 +/-0.07 mm, for th
Page 23 and 24: THYROID Cigarette smoking and thyro
Page 25 and 26: excluding from the cataract group t
Page 27 and 28: Long-Term Results of Lensectomy in
Page 29 and 30: CATARACT SURGERY Pediatric anterior
Page 31 and 32: Suture-related complications after
Page 33 and 34: included vitrectomy, capsulotomy, c
Page 35 and 36: medication. At the last follow-up,
Page 37 and 38: REFRACTIVE ERROR / REFRACTIVE SURGE
Page 39 and 40: demonstrated a positive effect on t
Page 41 and 42: ANTERIOR SEGMENT Conjunctival Melan
Page 43 and 44: RESULTS: Directly after birth, corn
Page 45 and 46: and photophobia (80%). The children
Page 47: Validity and reliability of the Chi
Page 51 and 52: METHODS: One hundred and thirteen c
Page 53 and 54: Verisyse intraocular lens implantat
Page 55 and 56: GENETICS Marfan syndrome: from mole
Page 57 and 58: Visual outcome of a cohort of child
Page 59 and 60: primarily affect the photoreceptors
Page 61 and 62: single morphogenetic anomaly in dev
Page 63 and 64: Three genome-wide association studi
Page 65 and 66: • Cafe-au-lait macules • Freckl
Page 67 and 68: Laryngeal and tracheal anomalies Po
Page 69 and 70: Treatment of retinoblastoma: Curren
Page 71 and 72: Secondary acute myeloid leukemia af
Page 73 and 74: one. Patients treated with radiatio
Page 75 and 76: Neuro-ophthalmological management o
Page 77 and 78: CONCLUSION: Canalicular involvement
Page 79 and 80: peripheral retinal vasculitis. The
Page 81 and 82: This article describes a 7-month-ol
Page 83 and 84: eference eyes. Photopic flash ERGs
Page 85 and 86: RESULTS: In models that adjusted fo
Page 87 and 88: ORBIT Porous orbital implants, wrap
Page 89 and 90: PLASTICS Conjunctival epithelial ch
Page 91 and 92: The authors conclude that lash ptos
Page 93 and 94: .03). SBP and DBP were significantl
Page 95 and 96: CONGENITAL INFECTION Congenital lym
Page 97 and 98: PEDIATRICS Visual Manifestations of
Page 99 and 100:
controversial, ranging from one to
Page 101 and 102:
SYSTEMIC Visual function and ocular
Page 103 and 104:
Toxocara infection. Toxocara GWC an
Page 105 and 106:
congenital cataracts. The retina wa
Page 107 and 108:
Childhood blindness: a UK epidemiol
Page 109:
safe and efficient procedure to cor
show all

What's new AAPOS 2008 - The Private Eye Clinic

Create successful ePaper yourself

Delete template?

Save as template?